Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study

被引:34
作者
Aravinthan, Aloysious D. [1 ,2 ,3 ]
Barbas, Andrew S. [1 ]
Doyle, Adam C. [1 ]
Tazari, Mahmood [1 ]
Sapisochin, Gonzalo [1 ]
Cattral, Mark S. [1 ]
Ghanekar, Anand [1 ]
McGilvray, Ian D. [1 ]
Selzner, Markus [1 ]
Greig, Paul D. [1 ]
Bhat, Mamatha [1 ]
Selzner, Nazia [1 ]
Grant, David R. [1 ]
Lilly, Leslie B. [1 ]
Renner, Eberhard L. [1 ,4 ]
机构
[1] Univ Toronto, Multiorgan Transplant Program, Toronto Gen Hosp, Toronto, ON, Canada
[2] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England
[3] Nottingham Univ Hosp NHS Trust, NIHR, Nottingham Biomed Res Ctr, Nottingham, England
[4] Univ Manitoba, Dept Med, Max Rady Coll Med, Rady Fac Hlth Sci, Winnipeg, MB, Canada
关键词
alcohol-related liver disease; delisting; model for end-stage liver disease score; recompensation; serum albumin; DECOMPENSATED CIRRHOSIS; HEPATITIS-C; LAMIVUDINE TREATMENT; VIRAL ERADICATION; NATURAL-HISTORY; LIVING DONOR; RECIPIENT; SURVIVAL; MODEL; CONSUMPTION;
D O I
10.1111/tri.13008
中图分类号
R61 [外科手术学];
学科分类号
摘要
Whether and when recovery beyond the need for transplant may occur in patients listed for decompensation remains unclear. This study aimed to investigate the characteristics of patients delisted following recompensation. Seventy-seven patients who were listed between 2005 and 2015 for decompensation, but later delisted following recompensation were included. Alcohol-related liver disease (ALD) was the underlying etiology in the majority (n = 47, 61%). Listing characteristics of these patients were compared with those of decompensated ALD patients who either underwent deceased donor liver transplantation or died on the waiting list. The model for end-stage liver disease (MELD) score <20 and serum albumin 32 g/l at listing were the only independent predictors of recompensation/delisting in ALD. The probability of recompensation was 70% when both factors were present at listing. Interestingly, about a tenth of decompensated ALD patients who died on the waiting list (median duration on waiting list 11 months) and a quarter of decompensated ALD patients who underwent living donor liver transplantation (median duration on waiting list 2 months) also had both factors at listing. In conclusion, ALD seems to be the most favorable etiology for recompensation beyond the need for transplantation. Both MELD and serum albumin at listing independently predict recompensation/delisting in ALD. It seems advisable to implement a period of observation for ALD patients with both favorable factors, before embarking on living donor liver transplantation.
引用
收藏
页码:1140 / 1149
页数:10
相关论文
共 28 条
[1]   Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study [J].
Belli, Luca Saverio ;
Berenguer, Marina ;
Cortesi, Paolo Angelo ;
Strazzabosco, Mario ;
Rockenschaub, Susanne-Rasoul ;
Martini, Silvia ;
Morelli, Cristina ;
Donato, Francesca ;
Volpes, Riccardo ;
Pageaux, Georges-Philippe ;
Coilly, Audrey ;
Fagiuoli, Stefano ;
Amaddeo, Giuliana ;
Perricone, Giovanni ;
Vinaixa, Carmen ;
Berlakovich, Gabriela ;
Facchetti, Rita ;
Polak, Wojciech ;
Muiesan, Paolo ;
Duvoux, Christophe .
JOURNAL OF HEPATOLOGY, 2016, 65 (03) :524-531
[2]   Liver Transplant Recipient Survival Benefit with Living Donation in the Model for Endstage Liver Disease Allocation Era [J].
Berg, Carl L. ;
Merion, Robert M. ;
Shearon, Tempie H. ;
Olthoff, Kim M. ;
Brown, Robert S., Jr. ;
Baker, Talia B. ;
Everson, Gregory T. ;
Hong, Johnny C. ;
Terrault, Norah ;
Hayashi, Paul H. ;
Fisher, Robert A. ;
Everhart, James E. .
HEPATOLOGY, 2011, 54 (04) :1313-1321
[3]   Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list [J].
Bonacci, Martin ;
Londono, Maria-Carlota ;
Esforzado, Nuria ;
Forns, Xavier ;
Sotoca, Jose-Miguel ;
Campistol, Josep-Maria .
TRANSPLANT INTERNATIONAL, 2015, 28 (11) :1345-1349
[4]   Drinking pattern is more strongly associated with under-reporting of alcohol consumption than socio-demographic factors: evidence from a mixed-methods study [J].
Boniface, Sadie ;
Kneale, James ;
Shelton, Nicola .
BMC PUBLIC HEALTH, 2014, 14
[5]   Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B [J].
Chang, Ting-Tsung ;
Liaw, Yun-Fan ;
Wu, Shun-Sheng ;
Schiff, Eugene ;
Han, Kwang-Hyub ;
Lai, Ching-Lung ;
Safadi, Rifaat ;
Lee, Samuel S. ;
Halota, Waldemar ;
Goodman, Zachary ;
Chi, Yun-Chan ;
Zhang, Hui ;
Hindes, Robert ;
Iloeje, Uchenna ;
Beebe, Suzanne ;
Kreter, Bruce .
HEPATOLOGY, 2010, 52 (03) :886-893
[6]   Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies [J].
D'Amico, G ;
Garcia-Tsao, G ;
Pagliaro, L .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :217-231
[7]   Histological outcome during long-term lamivudine therapy [J].
Dienstag, JL ;
Goldin, RD ;
Heathcote, EJ ;
Hann, HWL ;
Woessner, M ;
Stephenson, SL ;
Gardner, S ;
Gray, DF ;
Schiff, ER .
GASTROENTEROLOGY, 2003, 124 (01) :105-117
[8]   EASL Clinical Practice Guidelines: Liver transplantation [J].
Burra, Patrizia ;
Burroughs, Andrew ;
Graziadei, Ivo ;
Pirenne, Jacques ;
Valdecasas, Juan Carlos ;
Muiesan, Paolo ;
Samuel, Didier ;
Forns, Xavier ;
Burroughs, Andrew .
JOURNAL OF HEPATOLOGY, 2016, 64 (02) :433-485
[9]   All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study [J].
Fleming, Kate M. ;
Aithal, Guruprasad P. ;
Card, Tim R. ;
West, Joe .
LIVER INTERNATIONAL, 2012, 32 (01) :79-84
[10]   Prevention and management of Gastroesophageal varices and variceal Hemorrhage in cirrhosis [J].
Garcia-Tsao, Guadalupe ;
Sanyal, Arun J. ;
Grace, Norman D. ;
Carey, William .
HEPATOLOGY, 2007, 46 (03) :922-938